ENG/中
老虎證券
行情
交易
收费
优惠与活动
帮助
TigerAI
专栏
关于
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
DOGWOOD THERAPEUTICS INC
2.93
+0.0200
0.69%
盤後：
2.93
0.0000
0.00%
16:04 EST
成交量：
1.62萬
成交額：
4.89萬
市值：
9,755.61萬
市盈率：
-0.12
高：
3.06
開：
3.01
低：
2.93
收：
2.91
52周最高：
14.69
52周最低：
2.60
股本：
3,329.56萬
流通股本：
699.59萬
量比：
1.05
換手率：
0.23%
股息：
- -
股息率：
- -
每股收益(TTM):
-24.9248
每股收益(LYR):
-12.5160
淨資產收益率：
-930.96%
總資產收益率：
-42.04%
市淨率：
-2.95
市盈率(LYR):
-0.23
資料載入中...
總覽
公司
新聞資訊
公告
Dogwood Therapeutics宣佈Halneuron®二期B階段試驗完成50%患者入組，關鍵數據預計2026年第三季度公布
美股速递
·
02/02
Dogwood Therapeutics計劃於2026年底向FDA提交Halneuron二期研究總結、生產計劃及三期臨牀開發方案
美股速递
·
01/20
DOGWOOD THERAPEUTICS INC 2026年展望：Halneuron推進至2B期開發階段，最終數據預計於2026年第三季度公布
美股速递
·
01/20
Dogwood Therapeutics, Inc.盤中異動 快速拉升5.22%
市场透视
·
01/15
Dogwood Therapeutics公司獲2680萬美元孖展 推進Halneuron®二期B階段研發
美股速递
·
01/12
DOGWOOD THERAPEUTICS INC公布化療引起的神經病理性疼痛的積極中期2B臨牀試驗結果
美股速递
·
2025/12/22
Dogwood Therapeutics, Inc.盤中異動 快速跳水5.32%
市场透视
·
2025/12/19
DOGWOOD THERAPEUTICS INC - 與Northland Securities簽署股票分銷協議 - SEC備案
美股速递
·
2025/11/29
Dogwood Therapeutics 第三季度每股收益USD -8.2
投资观察
·
2025/11/20
Dogwood Therapeutics Inc通過全股票交易與Serpin Pharma達成協議，獲得SP16免版税許可
美股速递
·
2025/09/29
長江生命科技(00775)與DWTX訂立棄權協議
智通财经
·
2025/09/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DWTX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"DWTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DWTX\",,,,,undefined,":{"symbol":"DWTX","market":"US","secType":"STK","nameCN":"DOGWOOD THERAPEUTICS INC","latestPrice":2.93,"timestamp":1771621200000,"preClose":2.91,"halted":0,"volume":16224,"hourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.93,"latestTime":"16:04 EST","volume":2,"amount":5.86,"timestamp":1771621471133,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.006872852233676982,"floatShares":6995900,"shares":33295600,"eps":-24.9248,"marketStatus":"休市中","change":0.02,"latestTime":"02-20 16:00:00 EST","open":3.01,"high":3.06,"low":2.93,"amount":48896.5388,"amplitude":0.044674,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-24.9248,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1608181200000,"exchange":"NASDAQ","adjPreClose":2.91,"preHourTrading":{"tag":"盘前","latestPrice":2.91,"preClose":2.91,"latestTime":"08:00 EST","volume":315,"amount":917.5999770000001,"timestamp":1771592406038,"change":0,"changeRate":0,"amplitude":0.065292},"postHourTrading":{"tag":"盘后","latestPrice":2.93,"preClose":2.93,"latestTime":"16:04 EST","volume":2,"amount":5.86,"timestamp":1771621471133,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.050859},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DWTX\",,,,,undefined,":{"symbol":"DWTX","floatShares":6995900,"roa":"-42.04%","roe":"-930.96%","lyrEps":-12.516033,"volumeRatio":1.050859,"shares":33295600,"dividePrice":0,"high":3.06,"amplitude":0.044674,"preClose":2.91,"low":2.93,"week52Low":2.6,"pbRate":"-2.95","week52High":14.69,"institutionHeld":0,"latestPrice":2.93,"eps":-24.9248,"divideRate":0,"volume":16224,"delay":0,"ttmEps":-24.9248,"open":3.01,"prevYearClose":4.16,"prevWeekClose":3.07,"prevMonthClose":2.79,"prevQuarterClose":4.16,"fiveDayClose":3.02,"twentyDayClose":3.07,"sixtyDayClose":6.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DWTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"DWTX","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-8.2},{"market":"US","date":"2025-08-13","symbol":"DWTX","fiscalQuarterEnding":"2025/06","expectedEps":-1.26,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-1.99},{"market":"US","date":"2025-05-08","symbol":"DWTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"盤前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-4.21},{"market":"US","date":"2025-03-31","symbol":"DWTX","fiscalQuarterEnding":"2024/12","expectedEps":-1.49,"name":null,"time":"","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"","actualEps":-6.29},{"market":"US","date":"2024-10-09","symbol":"DWTX","defaultRemindTime":1728480600000,"type":"split","dateTimestamp":1728446400000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DWTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DWTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1745384400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DWTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DWTX","date":"2026-02-19","current":-0.117554,"percent":0.10355,"low":-5.30677,"twenty":-1.483967,"median":-0.573734,"eighty":-0.40908,"high":-0.31572,"avg":-1.060959,"sd":1.04602,"marketCap":99220747},"quantilePoints":[{"date":"2024-10-11","current":-0.88829,"twenty":-0.871777,"median":-0.847007,"eighty":-0.822237,"marketCap":4156676},{"date":"2024-10-18","current":-1.14168,"twenty":-1.243599,"median":-1.14168,"eighty":-0.919038,"marketCap":5342394},{"date":"2024-10-25","current":-1.352393,"twenty":-1.244175,"median":-1.155915,"eighty":-1.05342,"marketCap":6328406},{"date":"2024-10-31","current":-1.184386,"twenty":-1.27834,"median":-1.174407,"eighty":-1.098974,"marketCap":5542234},{"date":"2024-11-08","current":-1.035557,"twenty":-1.27834,"median":-1.184386,"eighty":-1.098974,"marketCap":5928592},{"date":"2024-11-15","current":-0.74467,"twenty":-1.269799,"median":-1.17156,"eighty":-0.88829,"marketCap":4263257},{"date":"2024-11-22","current":-0.6306,"twenty":-1.266952,"median":-1.124597,"eighty":-0.74467,"marketCap":3610202},{"date":"2024-11-29","current":-0.558465,"twenty":-1.264674,"median":-1.042032,"eighty":-0.629204,"marketCap":3197227},{"date":"2024-12-06","current":-0.532869,"twenty":-1.261826,"median":-0.94447,"eighty":-0.591959,"marketCap":3050687},{"date":"2024-12-13","current":-0.560792,"twenty":-1.247591,"median":-0.805175,"eighty":-0.586099,"marketCap":3210548},{"date":"2024-12-20","current":-0.53985,"twenty":-1.196344,"median":-0.717909,"eighty":-0.564981,"marketCap":3090652},{"date":"2024-12-27","current":-0.609658,"twenty":-1.179261,"median":-0.679489,"eighty":-0.564515,"marketCap":3490306},{"date":"2025-01-03","current":-0.584061,"twenty":-1.174695,"median":-0.665504,"eighty":-0.565461,"marketCap":3343766},{"date":"2025-01-10","current":-0.553811,"twenty":-1.172405,"median":-0.646888,"eighty":-0.565454,"marketCap":3170583},{"date":"2025-01-17","current":-0.449099,"twenty":-1.164457,"median":-0.623619,"eighty":-0.558465,"marketCap":2571103},{"date":"2025-01-24","current":-3.106463,"twenty":-1.170151,"median":-0.6306,"eighty":-0.558465,"marketCap":17784576},{"date":"2025-01-31","current":-2.969173,"twenty":-1.244175,"median":-0.653869,"eighty":-0.558465,"marketCap":16998591},{"date":"2025-02-07","current":-2.748114,"twenty":-1.269799,"median":-0.667831,"eighty":-0.560792,"marketCap":15733022},{"date":"2025-02-14","current":-1.561376,"twenty":-1.386529,"median":-0.691147,"eighty":-0.563119,"marketCap":8938914},{"date":"2025-02-21","current":-1.36824,"twenty":-1.406654,"median":-0.738827,"eighty":-0.564981,"marketCap":7833206},{"date":"2025-02-28","current":-1.095988,"twenty":-1.389852,"median":-0.805175,"eighty":-0.565476,"marketCap":6274558},{"date":"2025-03-07","current":-1.030834,"twenty":-1.384928,"median":-0.926984,"eighty":-0.569177,"marketCap":5901548},{"date":"2025-03-14","current":-1.798723,"twenty":-1.448286,"median":-1.000651,"eighty":-0.577546,"marketCap":10297735},{"date":"2025-03-21","current":-1.056947,"twenty":-1.431015,"median":-0.999453,"eighty":-0.58313,"marketCap":13053004},{"date":"2025-03-28","current":-0.925409,"twenty":-1.421838,"median":-0.979572,"eighty":-0.584992,"marketCap":11428545},{"date":"2025-04-04","current":-0.646858,"twenty":-1.406654,"median":-0.930825,"eighty":-0.586099,"marketCap":7988515},{"date":"2025-04-11","current":-0.317141,"twenty":-1.389852,"median":-0.88829,"eighty":-0.58313,"marketCap":3916603},{"date":"2025-04-17","current":-0.402359,"twenty":-1.385328,"median":-0.805724,"eighty":-0.565469,"marketCap":4969023},{"date":"2025-04-25","current":-0.61055,"twenty":-1.374755,"median":-0.785584,"eighty":-0.565469,"marketCap":7540127},{"date":"2025-05-02","current":-0.578189,"twenty":-1.358732,"median":-0.74467,"eighty":-0.568254,"marketCap":7140474},{"date":"2025-05-09","current":-0.374989,"twenty":-1.330168,"median":-0.724741,"eighty":-0.565469,"marketCap":8714743},{"date":"2025-05-16","current":-0.451467,"twenty":-1.293145,"median":-0.691147,"eighty":-0.558465,"marketCap":10492092},{"date":"2025-05-23","current":-0.435842,"twenty":-1.273215,"median":-0.667831,"eighty":-0.549157,"marketCap":10128978},{"date":"2025-05-30","current":-0.43502,"twenty":-1.26866,"median":-0.661674,"eighty":-0.542709,"marketCap":10109867},{"date":"2025-06-06","current":-0.424679,"twenty":-1.265813,"median":-0.656935,"eighty":-0.524492,"marketCap":9335860},{"date":"2025-06-13","current":-0.450325,"twenty":-1.262965,"median":-0.649201,"eighty":-0.469065,"marketCap":9899643},{"date":"2025-06-20","current":-0.417289,"twenty":-1.258453,"median":-0.635392,"eighty":-0.460532,"marketCap":9173414},{"date":"2025-06-27","current":-0.414681,"twenty":-1.246626,"median":-0.62674,"eighty":-0.450325,"marketCap":9116080},{"date":"2025-07-03","current":-0.417289,"twenty":-1.244175,"median":-0.623619,"eighty":-0.448744,"marketCap":9173414},{"date":"2025-07-11","current":-0.433807,"twenty":-1.191392,"median":-0.616057,"eighty":-0.435137,"marketCap":9536528},{"date":"2025-07-18","current":-0.413812,"twenty":-1.184386,"median":-0.61055,"eighty":-0.430908,"marketCap":9096969},{"date":"2025-07-25","current":-0.411204,"twenty":-1.175845,"median":-0.606188,"eighty":-0.428591,"marketCap":9039635},{"date":"2025-08-01","current":-0.420332,"twenty":-1.175104,"median":-0.602999,"eighty":-0.424679,"marketCap":9240303},{"date":"2025-08-08","current":-0.425287,"twenty":-1.172969,"median":-0.594948,"eighty":-0.422505,"marketCap":9349238},{"date":"2025-08-15","current":-0.380049,"twenty":-1.170151,"median":-0.588976,"eighty":-0.421636,"marketCap":9402749},{"date":"2025-08-22","current":-0.381594,"twenty":-1.165796,"median":-0.584643,"eighty":-0.419028,"marketCap":9440972},{"date":"2025-08-29","current":-0.370394,"twenty":-1.14168,"median":-0.579408,"eighty":-0.417298,"marketCap":9163858},{"date":"2025-09-05","current":-0.386229,"twenty":-1.128014,"median":-0.578189,"eighty":-0.417289,"marketCap":9555640},{"date":"2025-09-12","current":-0.378257,"twenty":-1.116602,"median":-0.565465,"eighty":-0.414688,"marketCap":9358411},{"date":"2025-09-19","current":-0.371892,"twenty":-1.1021,"median":-0.560792,"eighty":-0.413812,"marketCap":9200934},{"date":"2025-09-26","current":-0.394726,"twenty":-1.096585,"median":-0.556138,"eighty":-0.410856,"marketCap":9765864},{"date":"2025-10-03","current":-0.495918,"twenty":-1.064755,"median":-0.553811,"eighty":-0.413012,"marketCap":12269441},{"date":"2025-10-10","current":-0.519049,"twenty":-1.045015,"median":-0.552647,"eighty":-0.413742,"marketCap":12841707},{"date":"2025-10-17","current":-0.55705,"twenty":-1.036852,"median":-0.55705,"eighty":-0.413812,"marketCap":13781903},{"date":"2025-10-24","current":-0.520902,"twenty":-1.035502,"median":-0.552647,"eighty":-0.413812,"marketCap":12887570},{"date":"2025-10-31","current":-0.61637,"twenty":-1.031765,"median":-0.55705,"eighty":-0.414507,"marketCap":15249527},{"date":"2025-11-07","current":-0.481974,"twenty":-1.007156,"median":-0.555431,"eighty":-0.414681,"marketCap":11924442},{"date":"2025-11-14","current":-0.327725,"twenty":-1.000768,"median":-0.549157,"eighty":-0.413742,"marketCap":12520664},{"date":"2025-11-21","current":-0.357136,"twenty":-0.998735,"median":-0.545565,"eighty":-0.409242,"marketCap":13644313},{"date":"2025-11-28","current":-0.391355,"twenty":-0.987046,"median":-0.544503,"eighty":-0.403493,"marketCap":14951645},{"date":"2025-12-05","current":-0.368541,"twenty":-0.971236,"median":-0.53985,"eighty":-0.398837,"marketCap":14080014},{"date":"2025-12-12","current":-4.995522,"twenty":-0.987046,"median":-0.53985,"eighty":-0.39658,"marketCap":190852899},{"date":"2025-12-19","current":-4.746524,"twenty":-1.032696,"median":-0.544503,"eighty":-0.398429,"marketCap":181339982},{"date":"2025-12-26","current":-3.40816,"twenty":-1.050981,"median":-0.545001,"eighty":-0.398837,"marketCap":130208053},{"date":"2026-01-02","current":-3.236974,"twenty":-1.111477,"median":-0.549157,"eighty":-0.39905,"marketCap":123667922},{"date":"2026-01-09","current":-2.451074,"twenty":-1.16928,"median":-0.552647,"eighty":-0.399948,"marketCap":93642777},{"date":"2026-01-16","current":-2.351299,"twenty":-1.182678,"median":-0.557977,"eighty":-0.400578,"marketCap":89830899},{"date":"2026-01-23","current":-2.578032,"twenty":-1.247239,"median":-0.558465,"eighty":-0.402359,"marketCap":98493164},{"date":"2026-01-30","current":-2.435274,"twenty":-1.269799,"median":-0.561956,"eighty":-0.404249,"marketCap":93039145},{"date":"2026-02-06","current":-2.662007,"twenty":-1.36824,"median":-0.565484,"eighty":-0.407726,"marketCap":101701410},{"date":"2026-02-13","current":-2.536044,"twenty":-1.420694,"median":-0.572344,"eighty":-0.408596,"marketCap":96889041},{"date":"2026-02-19","current":-2.597076,"twenty":-1.483967,"median":-0.573734,"eighty":-0.40908,"marketCap":99220747}],"updateTime":1771653025624},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DWTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1160646340","title":"Dogwood Therapeutics宣佈Halneuron®二期B階段試驗完成50%患者入組，關鍵數據預計2026年第三季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1160646340","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160646340?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 21:32","pubTimestamp":1770039150,"startTime":"0","endTime":"0","summary":"生物制药公司Dogwood Therapeutics（股票代码：DWTX）近日披露，其核心候选药物Halneuron®的二期B阶段临床试验已完成半数患者入组。该试验旨在评估药物治疗特定适应症的有效性与安全性，目前进展符合预期时间表。\n公司明确表示，此次试验的关键顶线数据预计将于2026年第三季度正式对外公布。若结果达到临床终点，将为后续申报上市提供重要依据。\n市场对Halneuron®的商业潜力持续关注，该进展被视为公司研发管线推进的重要里程碑。Dogwood Therapeutics强调将严格遵循临床试验规范，确保数据收集的准确性与完整性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"1164963651","title":"Dogwood Therapeutics計劃於2026年底向FDA提交Halneuron二期研究總結、生產計劃及三期臨牀開發方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1164963651","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164963651?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 21:39","pubTimestamp":1768916372,"startTime":"0","endTime":"0","summary":"DOGWOOD THERAPEUTICS INC宣布，公司预计在2026年年底前向美国食品药品监督管理局（FDA）提交Halneuron药物二期临床试验的总结报告。此次提交内容将全面涵盖该阶段的研究数据与分析结论。\n同时，公司还将呈报详细的生产工艺方案以及三期临床试验的整体开发规划。这一系列提交标志着Halneuron项目从中期研究向关键性临床试验阶段推进的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"1190589246","title":"DOGWOOD THERAPEUTICS INC 2026年展望：Halneuron推進至2B期開發階段，最終數據預計於2026年第三季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1190589246","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190589246?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 21:35","pubTimestamp":1768916152,"startTime":"0","endTime":"0","summary":"DOGWOOD THERAPEUTICS INC在2026年将继续推进其候选药物Halneuron的临床开发进程，目前该药物已进入关键的2B期临床试验阶段。公司计划稳步推进相关研究工作，最终的2B期临床试验数据预计将在2026年第三季度正式对外公布。这一重要时间节点的设定，标志着Halneuron研发项目取得了实质性进展，也为后续的临床开发路径奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"2603986607","title":"Dogwood Therapeutics, Inc.盤中異動 快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603986607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603986607?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 04:43","pubTimestamp":1768423421,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日04时43分，Dogwood Therapeutics, Inc.股票出现波动，股价急速拉升5.22%。Dogwood Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Tango Therapeutics, Inc.、Sutro Biopharma, Inc.涨幅较大，Briacell Therapeutics Corp.、Clearmind Medicine Inc.、Nrx Pharmaceuticals, Inc.较为活跃，换手率分别为277.46%、82.38%、72.64%，振幅较大的相关个股有Alpha Tau Medical Ltd C/Wts 、Briacell Therapeutics Corp C/Wts 、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为56.54%、46.51%、41.18%。Dogwood Therapeutics, Inc.公司简介：Dogwood Therapeutics Inc前身为Virios Therapeutics Inc，是一家处于开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115044342953ccc68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115044342953ccc68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","BK4539","DWTX"],"gpt_icon":0},{"id":"1186306380","title":"Dogwood Therapeutics公司獲2680萬美元孖展 推進Halneuron®二期B階段研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1186306380","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186306380?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 21:34","pubTimestamp":1768224864,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics公司近日宣布成功获得高达2680万美元的融资支持，该笔资金将专项用于推进其核心候选药物Halneuron®完成二期临床试验B阶段的研究工作。此次融资将为Halneuron®的临床开发计划提供关键资源保障，标志着该创新疗法在神经疾病治疗领域迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1569","DWTX","00775","BK4139","BK1161"],"gpt_icon":0},{"id":"1184942557","title":"DOGWOOD THERAPEUTICS INC公布化療引起的神經病理性疼痛的積極中期2B臨牀試驗結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184942557","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184942557?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 23:17","pubTimestamp":1766416631,"startTime":"0","endTime":"0","summary":"DOGWOOD THERAPEUTICS INC公布了化疗引起的神经病理性疼痛中期2B临床试验的积极结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"2592184118","title":"Dogwood Therapeutics, Inc.盤中異動 快速跳水5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592184118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592184118?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 04:07","pubTimestamp":1766088444,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日04时07分，Dogwood Therapeutics, Inc.股票出现波动，股价快速下跌5.32%。Dogwood Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Athira Pharma, Inc.、Greenwich Lifesciences, Inc.涨幅较大，Athira Pharma, Inc.、Biodexa Pharmaceuticals Plc、Aditxt, Inc.较为活跃，换手率分别为1483.15%、291.20%、113.88%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、健永生技、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为65.12%、45.85%、44.39%。Dogwood Therapeutics, Inc.公司简介：Dogwood Therapeutics Inc前身为Virios Therapeutics Inc，是一家处于开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219040724953b6d41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219040724953b6d41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DWTX","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"1113120173","title":"DOGWOOD THERAPEUTICS INC - 與Northland Securities簽署股票分銷協議 - SEC備案","url":"https://stock-news.laohu8.com/highlight/detail?id=1113120173","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113120173?lang=zh_tw&edition=fundamental","pubTime":"2025-11-29 03:20","pubTimestamp":1764357619,"startTime":"0","endTime":"0","summary":"DOGWOOD THERAPEUTICS INC - 与Northland Securities签署股票分销协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"1162666202","title":"Dogwood Therapeutics 第三季度每股收益USD -8.2","url":"https://stock-news.laohu8.com/highlight/detail?id=1162666202","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162666202?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:59","pubTimestamp":1763571598,"startTime":"0","endTime":"0","summary":"11月6日 - Dogwood Therapeutics 第三季度净收入为USD -1,570万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"1127799873","title":"Dogwood Therapeutics Inc通過全股票交易與Serpin Pharma達成協議，獲得SP16免版税許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1127799873","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127799873?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 19:17","pubTimestamp":1759144670,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc宣布通过与Serpin Pharma的全股票交易，成功获得SP16项目的免版税许可权。此次交易将为Dogwood Therapeutics Inc在相关治疗领域的发展提供重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"gpt_icon":0},{"id":"2570882552","title":"長江生命科技(00775)與DWTX訂立棄權協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2570882552","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570882552?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 22:24","pubTimestamp":1758896694,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 发布公告，诚如首份公告所披露，根据售股协议，向卖方发行买方普通股付款股份及买方Dogwood Therapeutics, Inc优先股付款股份乃作为向买方出售目标公司100%股权的代价，及买方优先股付款股份为卖方提供现金结算权及回购权。于2025年9月26日，卖方与买方订立弃权协议，双方同意就部分买方优先股付款股份放弃现金结算权及回购权。自首份公告及第二份公告以来，买方已公布 Halneuron 临床试验的进一步进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","DWTX","BK4139","00775","BK1569"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}